Site Search

 Poll
What is your favorite kind of music?
Cast your vote

Getting Poll Results
(Reuters) - An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster. . . more
(Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday. . . more
Mon, 23 Apr 2018 10:16:31 -0400 
WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday. . . more
(Reuters Health) - Electromagnetic fields produced by motors in electric cars dont appear strong enough to interfere with implanted heart devices like pacemakers and defibrillators, a small German study suggests. . . more
(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information. . . more
Mon, 23 Apr 2018 18:49:54 -0400 
(Reuters Health) - Women who are heavy drinkers are at increased risk of pre-menstrual syndrome (PMS), new research shows. . . more
(Reuters Health) - Teens who use e-cigarettes may be twice as likely to smoke pot as their peers who never try vaping, a U.S. study suggests. . . more
LONDON (Reuters) - Shares in Prothena, a biotech company backed by British investor Neil Woodford, plunged 70 percent on Monday after its main drug for treating a rare disease called AL amyloidosis failed in a crucial clinical trial. . . more
(Reuters Health) - Female researchers may be less successful at winning grant funding than their male counterparts with similar experience and qualifications at least in part because of gender bias among reviewers, a Canadian study suggests. . . more
Mon, 23 Apr 2018 10:50:02 -0400 
FRANKFURT (Reuters) - U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement. . . more


Free Online Games from NickeySurf.com